Kendal Whitlock

Formerly at Boehringer Ingelheim GmbH & Co KG, USA, Co-Leader at Decentralized Trials Research Alliance (DTRA) 3C Decentralized Research Curriculum, USA

Kendal K. Whitlock leads Healthcare Provider (HCP) network growth, change management/community engagement, and education for digital trials at Boehringer Ingelheim (BI). In this role, she developed the global HCP engagement strategy, and liaises with all other clinical trial enabling functions to establish a customized investigator network.

Kendal holds an MPH from Columbia University, and is currently working toward her doctorate. She values patient empowerment, health equity and the ethics of tech design. She is the Chair of the Product Development and Clinical Research for the Med Tech Color Collaborative Community and the Co-Lead for the Decentralized Trials Research Alliance (DTRA).